drugset / Trial / NCT00269594

An Open-Label Study Of Lamictal In Neurotic Excoriation

NCT00269594

Phase 2 Completed 25 enrolled University of Minnesota
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The goal of the proposed study is to evaluate the efficacy and safety of Lamictal in neurotic excoriation. Twenty subjects with neurotic excoriation will receive 12 weeks of open-label treatment with Lamictal. The hypothesis to be tested is that Lamictal will be effective and well tolerated in patients with neurotic excoriation. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.

Timeline

Start
2006-01
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 25 mg
Subject Lamotrigine Small molecule 200 mg
Subject Lamotrigine Small molecule 300 mg